November 25, 2020November 25, 2020
AlzeCure’s Lead Therapy Candidate Entering Phase 1 Testing in Sweden
News
AlzeCure Pharma is preparing to launch a Phase 1 clinical trial in Sweden to evaluate the tolerability and safety ... Read more
November 23, 2020November 19, 2020
Don’t Let Alzheimer’s Disease Steal Thanksgiving
Columns, Treading Dark Waters - a Column by Ray Burow
As exampled by the Pilgrims and the Indigenous people who graced the first Thanksgiving table, families in the United ... Read more
November 23, 2020November 23, 2020
Gum Disease Bacteria Found in Most Alzheimer’s Patients in Atuzaginstat Trial
News
Most of the mild to moderate Alzheimer’s patients enrolled in the atuzaginstat (COR388) Phase 2/3 trial show evidence of systemic infection due ... Read more
November 18, 2020November 18, 2020
Last Participant Finishes PEGASUS Clinical Trial, Results Expected Next Year
News
The last participant has completed the planned 24 weeks in the Phase 2 PEGASUS clinical trial, which is assessing ... Read more
November 16, 2020November 12, 2020
Finding Nursing Home Placement for a Loved One With Alzheimer’s
Columns, Treading Dark Waters - a Column by Ray Burow
In the early days of diagnosis and the early stages of Alzheimer’s disease, a caregiver is capable of sufficiently ... Read more
November 16, 2020November 16, 2020
FDA Clears Neuraly to Begin Phase 2 Trial of NLY01 in Alzheimer’s Patients
News
The U.S. Food and Drug Administration has given clearance for a Phase 2B clinical trial to evaluate the safety, ... Read more
November 11, 2020November 11, 2020
FDA Committee Votes Do Not Support Aducanumab as Effective Treatment
News
An advisory arm of the U.S. Food and Drug Administration (FDA) is recommending that available clinical data on aducanumab ... Read more
November 9, 2020November 5, 2020
National Family Caregivers Month Is a Chance to Spread Happiness
Columns, Treading Dark Waters - a Column by Ray Burow
The act of giving thanks is good for the soul. In fact, gratefulness has been linked to happiness, according ... Read more
November 9, 2020November 9, 2020
EMA Agrees to Review Biogen, Eisai Request for Aducanumab’s Approval
News
The European Medicines Agency (EMA) has agreed to review Biogen and Eisai’s application requesting the approval of aducanumab (BIIB037) for ... Read more
November 4, 2020November 4, 2020
Awareness Month Activities Shine Spotlight on Alzheimer’s, Dementia
News
Efforts are underway this month to focus attention on Alzheimer’s, a disease that, along with other forms of dementia, affects ... Read more
November 2, 2020October 29, 2020
Infrastructure Is Needed to Support Familial Caregivers
Columns, Treading Dark Waters - a Column by Ray Burow
On Tuesday, the American people will elect the president of the United States, and unless you can see into ... Read more
November 2, 2020November 2, 2020
Seth Rogen’s HFC ‘Game Show’ Raises $325K to Benefit Alzheimer’s Care
News
Using levity to battle a serious disease, entertainer Seth Rogen and his wife raised more than $325,000 for HFC, the couple’s ... Read more

Author Details

Joe Pierce

November 25, 2020November 25, 2020

AlzeCure’s Lead Therapy Candidate Entering Phase 1 Testing in Sweden

News

AlzeCure Pharma is preparing to launch a Phase 1 clinical trial in Sweden to evaluate the tolerability and safety of ACD856, one of its therapy candidates for Alzheimer’s disease, ... Read more

November 23, 2020November 19, 2020

Don’t Let Alzheimer’s Disease Steal Thanksgiving

Columns, Treading Dark Waters - a Column by Ray Burow

As exampled by the Pilgrims and the Indigenous people who graced the first Thanksgiving table, families in the United States gather each year to give thanks. The gateway to ... Read more

November 23, 2020November 23, 2020

Gum Disease Bacteria Found in Most Alzheimer’s Patients in Atuzaginstat Trial

News

Most of the mild to moderate Alzheimer’s patients enrolled in the atuzaginstat (COR388) Phase 2/3 trial show evidence of systemic infection due to Porphyromonas gingivalis, a bacteria linked to periodontal disease whose toxic enzymes ... Read more

November 18, 2020November 18, 2020

Last Participant Finishes PEGASUS Clinical Trial, Results Expected Next Year

News

The last participant has completed the planned 24 weeks in the Phase 2 PEGASUS clinical trial, which is assessing the safety and biological activity of Amylyx Pharmaceuticals‘ investigational therapy ... Read more

November 16, 2020November 12, 2020

Finding Nursing Home Placement for a Loved One With Alzheimer’s

Columns, Treading Dark Waters - a Column by Ray Burow

In the early days of diagnosis and the early stages of Alzheimer’s disease, a caregiver is capable of sufficiently providing for their loved one. The person within their care ... Read more

November 16, 2020November 16, 2020

FDA Clears Neuraly to Begin Phase 2 Trial of NLY01 in Alzheimer’s Patients

News

The U.S. Food and Drug Administration has given clearance for a Phase 2B clinical trial to evaluate the safety, tolerability, and efficacy of Nueraly‘s investigational therapy NLY01 in people ... Read more

November 11, 2020November 11, 2020

FDA Committee Votes Do Not Support Aducanumab as Effective Treatment

News

An advisory arm of the U.S. Food and Drug Administration (FDA) is recommending that available clinical data on aducanumab (BIIB037) does not support the effectiveness of this investigational therapy ... Read more

November 9, 2020November 5, 2020

National Family Caregivers Month Is a Chance to Spread Happiness

Columns, Treading Dark Waters - a Column by Ray Burow

The act of giving thanks is good for the soul. In fact, gratefulness has been linked to happiness, according to Harvard Health Publishing. “Gratitude helps people feel more positive ... Read more

November 9, 2020November 9, 2020

EMA Agrees to Review Biogen, Eisai Request for Aducanumab’s Approval

News

The European Medicines Agency (EMA) has agreed to review Biogen and Eisai’s application requesting the approval of aducanumab (BIIB037) for the treatment of Alzheimer’s disease. The companies’ approval request — ... Read more

November 4, 2020November 4, 2020

Awareness Month Activities Shine Spotlight on Alzheimer’s, Dementia

News

Efforts are underway this month to focus attention on Alzheimer’s, a disease that, along with other forms of dementia, affects some 44 million people globally and is swiftly growing in ... Read more